Th22 Cells as Well as Th17 Cells Expand Differentially in Patients with Early-Stage and Late-Stage Myelodysplastic Syndrome

BACKGROUND: Immunological mechanisms are increasingly recognized in the progression of myelodysplastic syndrome (MDS). Early-stage MDS (E-MDS) is characterized by autoimmune-mediated myelosuppression whereas late-stage MDS (L-MDS) involves immune evasion, giving dysplastic cells growth potential to...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Lin-lin, Zhang, Lei, Hou, Yu, Yu, Shuang, Liu, Xin-guang, Huang, Xiao-yang, Sun, Yuan-xin, Tian, Tian, He, Na, Ma, Dao-xin, Peng, Jun, Hou, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517399/
https://www.ncbi.nlm.nih.gov/pubmed/23236476
http://dx.doi.org/10.1371/journal.pone.0051339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517399/
https://www.ncbi.nlm.nih.gov/pubmed/23236476
http://dx.doi.org/10.1371/journal.pone.0051339

Ejemplares similares